Author

Yu-Jie Zhou

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Aug 2026

Biohybrid Fused-Cell Carrier for Programmable Therapeutic Modulation of Atherosclerosis.

Cardiovascular disease, driven primarily by atherosclerosis, remains a leading cause of global mortality. Lipid-lowering therapies reduce risk by less than one-third, leaving substantial residual inflammation compounded by rapid drug clearance and limited plaque targeting. Biomimetic systems such as cell-membrane coati...

Guanghao Wu, Jiefang Sun, Yu-Jie Zhou et al. · Nano letters (Print) · 0 citations

Open access Aug 2026

Clopidogrel Versus Dual-Antiplatelet Therapy for Long-Term Maintenance After Coronary Stenting in Ischemic and Bleeding Birisk Patients With Acute Coronary Syndromes and Diabetes: A Prespecified Subgroup Analysis of the OPT-BIRISK Trial.

In birisk patients with acute coronary syndrome who were stable on dual-antiplatelet therapy with clopidogrel plus aspirin for 9 to 12 months after percutaneous coronary intervention, clopidogrel monotherapy for an additional 9 months reduced clinically relevant bleeding without increasing ischemic events compared with...

Dali Zhang, Yi Li, Miao-Han Qiu et al. · Journal of the American Hear... · 0 citations